PDL BioPharma Inc. (OTCMKTS:PDLI) Raises $150 million Through Offering of Unsecured Convertible Notes

PDL BioPharma Inc. (OTCMKTS:PDLI) recently attended the Piper Jaffray Healthcare Conference, held in New York, on November 29, 2016. The company was represented by its CEO, John P. McLaughlin, whose presentation was also webcast live, on PDLI’s website. It should be noted that this was the 28th time the annual conference was held. The presentation […]